Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention

Completed · Phase 4

Conditions studied: Traumatic Brain Injury, Subarachnoid Hemorrhage

In brief

To show that the use of intravenous levetiracetam(LEV;Keppra)for seizure prevention in patients in the Neuroscience Intensive Care Unit will result in fewer side effects compared to the current standard of care anticonvulsant and will be at least as effective as the current standard of care in preventing clinical and sub-clinical seizure activity.

Key facts

Study ID
NCT00618436
Run by
University of Cincinnati
People needed
52
Starts
2007-08-01
Expected to finish
2009-09-01
Last updated by the study team
2014-04-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.